Sort
39,280 grants matching “leukemia”
Genetic Analysis of the Zebrafish Somitogenesis Oscillator
$464,814Scott A Holley · Yale University · R01 · FY2009 · HD
THE ROLE OF SELENOPROTEIN SYNTHESIS PATHWAY IN ACUTE MYELOID LEUKEMIA
$464,800Daisuke Nakada · Baylor College Of Medicine · R01 · FY2025 · CA
THE ROLE OF SELENOPROTEIN SYNTHESIS PATHWAY IN ACUTE MYELOID LEUKEMIA
$464,800Daisuke Nakada · Baylor College Of Medicine · R01 · FY2021 · CA
Targeting NSD1 in leukemia
$464,783Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Tumor maintenance and development in mouse models
$464,773Harold E Varmus · Sloan-Kettering Inst Can Research · U01 · FY2008 · CA
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
$464,700Michael A Caligiuri · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
An innovative integrated computational framework using gene signatures for patient stratification
$464,640Chao Cheng · Baylor College Of Medicine · R01 · FY2023 · CA
DOXORUBICIN CARDIOMYOPATHY: MOLECULAR GENETICS &RESCUE
$464,568University Of Southern California · R01 · FY2003 · HL
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
$464,516Ann Marie Pendergast · Duke University · R01 · FY2023 · CA
Mechanisms of targeting cellular self-renewal in glioblastoma
$464,444Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Microchimerism as AlloImmunity
$464,427J. Lee Lee Nelson · Fred Hutchinson Cancer Research Center · R01 · FY2015 · HL
Astrocytes in Retrovirus-Induced Spongiform Motor Neuron Disease
$464,412William P Lynch · Northeast Ohio Medical University · R15 · FY2018 · NS
Phase I Clinical Trials of Novel Agents
$464,385Naiyer A Rizvi · Sloan-Kettering Inst Can Research · U01 · FY2007 · CA
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival
$464,372Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Targeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms
$464,330Gary W Reuther · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · HL
Clinical, Immunological and Genetic Analyses of ALPS and Related Disordrs
$464,319Vemulkonda Rao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
The Role of CREB in Normal Myelopoiesis and Leukemogenesis
$464,302Kathleen Miho Sakamoto · Stanford University · R01 · FY2012 · HL
NMR Studies of Retroviral Nucleic Acid Binding Proteins
$464,298Michael F. Summers · University Of Maryland Baltimore County · R01 · FY2014 · GM
Flow Cytometric Evaluation of Biomarkers
$464,254Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)
$464,153Susan L Slager · Mayo Clinic Rochester · R01 · FY2022 · AG
Using natural antibodies to improve vaccines
$464,084John J Iacomini · Brigham And Women'S Hospital · R01 · FY2010 · AI
Glia maturation factor-gamma modulation of signaling pathways in macrophages
$464,033Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Preclinical Diagnostic Imaging of Amyloid
$464,016Jonathan S Wall · University Of Tennessee Knoxville · R01 · FY2009 · DK
Mechanism of Therapy in high-risk AML
$463,996Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · CA
Targeted Lipopolyplexes for Oligonucleotide Delivery to AML
$463,970Robert J. Lee · Ohio State University · R01 · FY2010 · CA